Skip Navigation


IJE Advance Access originally published online on October 28, 2004
International Journal of Epidemiology 2005 34(1):166-172; doi:10.1093/ije/dyh347
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/1/166    most recent
dyh347v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smyth, B. P
Right arrow Articles by Keenan, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smyth, B. P
Right arrow Articles by Keenan, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

IJE vol.34 no.1 © International Epidemiological Association 2004; all rights reserved.

Article

Irish injecting drug users and hepatitis C: the importance of the social context of injecting

Bobby P Smyth1,2,*, Joe Barry3 and Eamon Keenan1

1 Addiction Service, Bridge House, Cherry Orchard Hospital, Dublin 10, Ireland
2 Present address: Department of Public Health and Primary Care, Trinity College, Dublin, Ireland
3 Department of Public Health and Primary Care, Trinity College, Dublin, Ireland

* Corresponding author. Department of Public Health and Primary Care, Trinity Centre for Health Sciences, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland. E-mail: bobby.smyth{at}swahb.ie

Background The incidence of hepatitis C (HCV) infection among injecting drug users (IDUs) in Dublin is particularly high by international standards. The most robust predictor of an IDU's HCV status is his or her total number of lifetime injecting episodes. It has been proposed that participation in specific unsafe injecting practices is the principal contributor to this accumulated risk. We sought to test this hypothesis. The relationship between social context of injecting and HCV status was also examined.

Methods We conducted a cross-sectional survey of IDUs recruited from treatment settings in Dublin. Participants had injected in the preceding six months and had not previously been tested for HCV. A structured interview was conducted.

Results HCV testing was performed on 159 IDUs, and 61% were antibody positive. The three characteristics that were significant independent predictors of a positive test result were increased total number of lifetime injecting episodes, closer social relationships with other IDUs, and injecting in the home of other IDUs. Frequency of recipient syringe sharing (i.e. borrowing used syringes from other IDUs), backloading, and sharing of injecting paraphernalia were not independently associated with infection.

Conclusions We found that the robust association between HCV infection and number of lifetime injecting episodes was not explained by increased unsafe injecting practices. The socialized nature of heroin injecting in Dublin is contributing to the HCV epidemic in this population. Our findings suggest that accidental and unnoticed sharing of injecting equipment may be an important contributor to an IDU's increasing risk of infection over time.


Keywords Hepatitis C, injecting drug users, risk factors, syringe sharing, social context

Accepted 2 September 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Public HealthHome page
L. Platt, A. J. Sutton, P. Vickerman, E. Koshkina, S. Maximova, N. Latishevskaya, M. Hickman, C. Bonell, J. Parry, and T. Rhodes
Measuring risk of HIV and HCV among injecting drug users in the Russian Federation
Eur J Public Health, August 1, 2009; 19(4): 428 - 433.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
P Vickerman, L Platt, and S Hawkes
Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan
Sex Transm Inf, April 1, 2009; 85(Suppl_2): ii23 - ii30.
[Abstract] [Full Text] [PDF]


Home page
Int J STD AIDSHome page
M C Mendes-Correa, N P Cavalheiro, C Mello, A A Barone, and R J Gianini
Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil
Int J STD AIDS, September 1, 2008; 19(9): 595 - 599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C.-Q. Wang, Y. Li, S. D. Douglas, X. Wang, D. S. Metzger, T. Zhang, and W.-Z. Ho
Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression
Am. J. Pathol., November 1, 2005; 167(5): 1333 - 1340.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.